'Sanofi Taps Adviser For OTC Spinoff As Buyout Firms Circle; French Pharma Firm Working With Rothschild On Separate Listing; Private Equity Funds Eye Sanofi Arm Valued At Over $20B'

'Sanofi Taps Adviser For OTC Spinoff As Buyout Firms Circle; French Pharma Firm Working With Rothschild On Separate Listing; Private Equity Funds Eye Sanofi Arm Valued At Over $20B' - Bloomberg News

-0.37%

Sanofi Sponsored ADR

SNY

48.68

-0.37%

https://www.bloomberg.com/news/articles/2023-11-15/sanofi-taps-adviser-for-otc-spinoff-as-buyout-firms-circle

Sanofi is working with an adviser to start preparations for a planned separation of its consumer health division, people with knowledge of the matter said.

Paris-based Sanofi is in the early stages of speaking with Rothschild & Co. about a separate listing of the business, which could be valued at more than $20 billion in any deal, the people said.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.